Tuesday, April 29, 2025

Latest

Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of directors with accomplished executives and thought leaders in the medical space with the appointment of Dr Bill Wilkerson, LL.D (Hon).

Dr Wilkerson is a highly accomplished executive in the areas of business, government, broadcasting, arts, and corporate crisis management. He has been an 8-time award-winner in workplace mental health, following an international initiative conducted from 1998 to 2012 to enforce the significance of mental health among major employers.

In terms of previous employment, Dr Wilkerson was previously President of Liberty Health, one of Canada’s largest benefits providers, and held executive roles at RBC, CBC, and the Toronto Symphony Orchestra. As an adviser for mental health, his career has been just as impressive, having worked with the NHL, the CFL, the Hockey Hall of Fame, Toronto Blue Jays, TSN, CTV, and more.

"I am pleased to join the board of directors of Champignon to help deploy, at long last, treatments of depression that work, work fast, restore health, fuel hope, animate workplace productivity, and save lives. The mission of this company is fundamental and enduring; to meet a pressing public need. This is what my twenty-two years of advocacy for mental health in the workplace has been all about. This directorship also permits me to support and help facilitate the vision of the extraordinarily skilled and dedicated physician-scientist Dr. Roger McIntyre, a world leader in a field that cries out for his kind of resolve, courage, compassion, and knowledge. I am humbled by, and grateful for, the opportunity to serve." 
Dr Bill Wilkerson

In conjunction with the appointment of Dr Bill Wilkerson, Joe Perino has resigned from Champignon’s board of directors.

Champignon Brands last traded at $1.63 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program...

Monday, June 8, 2020, 10:03:37 AM

Champignon Brands Vs Mind Medicine: A Comparison

Champignon Brands (CSE: SHRM), prior to the public listing of the company, had a primary...

Monday, April 20, 2020, 09:01:13 AM

Champignon Brands Appoints Dr Roger McIntyre As CEO

Champignon Brands (CSE: SHRM) this morning announced that it has named Dr Roger McIntyre as...

Monday, May 11, 2020, 09:48:09 AM

Champignon Brands Announces Voluntary Share Lockup Agreement

Champignon Brands (CSE: SHRM) this morning announced that certain of the firms shareholders have agreed...

Friday, May 29, 2020, 08:23:52 AM

Champignon Brands To Acquire Psilocybin Research Firm Tassili Life Sciences

Last night, Champignon Brands (CSE: SHRM) announced that they have signed a definitive agreement to...

Saturday, March 28, 2020, 01:12:34 PM